164 related articles for article (PubMed ID: 29339543)
21. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer.
Soto JA; Rodríguez-Antolín C; Vera O; Pernía O; Esteban-Rodríguez I; Dolores Diestro M; Benitez J; Sánchez-Cabo F; Alvarez R; De Castro J; Ibanez de Cáceres I
Clin Epigenetics; 2021 Aug; 13(1):167. PubMed ID: 34454589
[TBL] [Abstract][Full Text] [Related]
23. A low-input high resolution sequential chromatin immunoprecipitation method captures genome-wide dynamics of bivalent chromatin.
Seneviratne JA; Ho WWH; Glancy E; Eckersley-Maslin MA
Epigenetics Chromatin; 2024 Feb; 17(1):3. PubMed ID: 38336688
[TBL] [Abstract][Full Text] [Related]
24. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells.
Rodriguez J; Muñoz M; Vives L; Frangou CG; Groudine M; Peinado MA
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19809-14. PubMed ID: 19060200
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
Staub J; Chien J; Pan Y; Qian X; Narita K; Aletti G; Scheerer M; Roberts LR; Molina J; Shridhar V
Oncogene; 2007 Jul; 26(34):4969-78. PubMed ID: 17310998
[TBL] [Abstract][Full Text] [Related]
26. Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.
Flanagan JM; Wilson A; Koo C; Masrour N; Gallon J; Loomis E; Flower K; Wilhelm-Benartzi C; Hergovich A; Cunnea P; Gabra H; Braicu EI; Sehouli J; Darb-Esfahani S; Vanderstichele A; Vergote I; Kreuzinger C; Castillo-Tong DC; Wisman GBA; Berns EM; Siddiqui N; Paul J; Brown R
Clin Cancer Res; 2017 May; 23(9):2213-2222. PubMed ID: 27663594
[No Abstract] [Full Text] [Related]
27. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
29. Dissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene Cadm1.
Reamon-Buettner SM; Borlak J
PLoS One; 2012; 7(6):e38531. PubMed ID: 22701659
[TBL] [Abstract][Full Text] [Related]
30. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
31. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.
Ku M; Koche RP; Rheinbay E; Mendenhall EM; Endoh M; Mikkelsen TS; Presser A; Nusbaum C; Xie X; Chi AS; Adli M; Kasif S; Ptaszek LM; Cowan CA; Lander ES; Koseki H; Bernstein BE
PLoS Genet; 2008 Oct; 4(10):e1000242. PubMed ID: 18974828
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.
Bonito NA; Borley J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Brown R
Clin Cancer Res; 2016 Jun; 22(12):3097-3104. PubMed ID: 26763252
[TBL] [Abstract][Full Text] [Related]
33. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
[TBL] [Abstract][Full Text] [Related]
34. Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer.
Iliou MS; Lujambio A; Portela A; Brüstle O; Koch P; Andersson-Vincent PH; Sundström E; Hovatta O; Esteller M
Epigenetics; 2011 Nov; 6(11):1344-53. PubMed ID: 22048248
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells.
Mayor R; Muñoz M; Coolen MW; Custodio J; Esteller M; Clark SJ; Peinado MA
Epigenetics; 2011 Sep; 6(9):1138-48. PubMed ID: 21852760
[TBL] [Abstract][Full Text] [Related]
36. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
37. Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation.
Tennakoon JB; Wang H; Coarfa C; Cooney AJ; Gunaratne PH
PLoS One; 2013; 8(9):e74556. PubMed ID: 24040281
[TBL] [Abstract][Full Text] [Related]
38. Chromatin signature of embryonic pluripotency is established during genome activation.
Vastenhouw NL; Zhang Y; Woods IG; Imam F; Regev A; Liu XS; Rinn J; Schier AF
Nature; 2010 Apr; 464(7290):922-6. PubMed ID: 20336069
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
[TBL] [Abstract][Full Text] [Related]
40. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells.
Gao F; Ji G; Gao Z; Han X; Ye M; Yuan Z; Luo H; Huang X; Natarajan K; Wang J; Yang H; Zhang X
Genomics; 2014; 103(2-3):204-10. PubMed ID: 24407023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
